EUVIMEDEUVIMED entdecken
Crossref

No prognostic impact of staging bone scan in patients with stage IA non-small cell lung cancer

Xia Zheng, Chunxia Li, Jing Ai, Guili Dong, Man Long, Mingyi Li, Shilin Qiu, Yanni Huang, Guangjun Yang, Tao Zhang, Zhenhui Li

Annals of Nuclear Medicine · 2024

DOI: 10.1007/s12149-024-01927-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Nuclear Medicine, 2024. Verfasst von Xia Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, No. 519 Kunzhou R…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Staging, Bone Neoplasms. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Yunnan digitalization, development and application of biotic resource, The Outstanding Youth Science Foundation of Yunnan Basic Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To investigate the survival benefit of preoperative bone scan in asymptomatic patients with early-stage non-small cell lung cancer (NSCLC). METHODS: This retrospective study included patients with radical resection for stage T1N0M0 NSCLC between March 2013 and December 2018. During postoperative follow-up, we monitored patient survival and the development of bone metastasis. We compared overall survival, bone metastasis-free survival, and recurrence-free survival in patients with or without preoperative bone scan. Propensity score matching and inverse probability of treatment weighting were used to minimize election bias. RESULTS: A total of 868 patients (58.19 ± 9.69 years; 415 men) were included in the study. Of 87.7% (761 of 868) underwent preoperative bone scan. In the multivariable analyses, bone scan did not improve overall survival (hazard ratio [HR] 1.49; 95% confidence intervals [CI] 0.91-2.42; p = 0.113), bone metastasis-free survival (HR 1.18; 95% CI 0.73-1.90; p = 0.551), and recurrence-free survival (HR 0.89; 95% CI 0.58-1.39; p = 0.618). Similar results were obtained after propensity score matching (overall survival [HR 1.28; 95% CI 0.74-2.23; p = 0.379], bone metastasis-free survival [HR 1.00; 95% CI 0.58-1.72; p = 0.997], and recurrence-free survival [HR 0.76; 95% CI 0.46-1.24; p = 0.270]) and inverse probability of treatment weighting. CONCLUSION: There were no significant differences in overall survival, bone metastasis-free survival, and recurrence-free survival between asymptomatic patients with clinical stage IA NSCLC with or without preoperative bone scan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsNeoplasm StagingBone NeoplasmsHumansMaleFemaleMiddle AgedRetrospective StudiesPrognosisAgedBone and Bones

Stichwörter der Autor:innen

Bone metastasisBone scanNon-small cell lung cancerPrognosis

Autor:innen und Institutionen

  • Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, No. 519 Kunzhou Road, Xishan District, Kunming, 650118, Yunnan, China.
  • Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Department of Nuclear Medicine, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming, 650118, China.
  • Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, No. 519 Kunzhou Road, Xishan District, Kunming, 650118, Yunnan, China. lizhenhui@kmmu.e…

Förderung

  • National Natural Science Foundation of China
  • Yunnan digitalization, development and application of biotic resource
  • The Outstanding Youth Science Foundation of Yunnan Basic Research Project
  • The Yunnan Basic Research Project

Zitieren

APA

Zheng, X., Li, C., Ai, J., Dong, G., Long, M., Li, M., Qiu, S., Huang, Y., Yang, G., Zhang, T., & Li, Z. (2024). No prognostic impact of staging bone scan in patients with stage IA non-small cell lung cancer. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-024-01927-3

Vancouver

Zheng X, Li C, Ai J, Dong G, Long M, Li M, et al. No prognostic impact of staging bone scan in patients with stage IA non-small cell lung cancer. Annals of Nuclear Medicine. 2024. doi:10.1007/s12149-024-01927-3

BibTeX
@article{Zheng2024,
  author = {Zheng, Xia and Li, Chunxia and Ai, Jing and Dong, Guili and Long, Man and Li, Mingyi and Qiu, Shilin and Huang, Yanni and Yang, Guangjun and Zhang, Tao and Li, Zhenhui},
  title = {No prognostic impact of staging bone scan in patients with stage IA non-small cell lung cancer},
  journal = {Annals of Nuclear Medicine},
  year = {2024},
  doi = {10.1007/s12149-024-01927-3}
}
Kostenlos starten →